Literature DB >> 24867068

Potential benefit of dehydroepiandrosterone supplementation for infertile but not poor responder patients in a IVF program.

M Tartagni1, G De Pergola, G R Damiani, A Pellegrino, D Baldini, M V Tartagni, H Alrasheed, M A De Salvia, G Loverro.   

Abstract

AIM: The aim of this paper was to evaluate the hypothesis that pretreatment with dehydroepiandrosterone (DEHA) may improve the result on in vitro fertilization (IVF) and the pregnancy outcome among infertile women with normal ovarian reserve.
METHODS: Double-blind, randomized, placebo-controlled study; 52 infertile patients received the long protocol IVF. Patients in Group 1, received 75 mg of DHEA once a day, 8 weeks before starting the IVF cycle and during treatment; control group (Group 2) received placebo. The primary endpoint was pregnancy, live birth and miscarriage rates, secondary endpoint was standard IVF parameters such us stimulation duration (hCG day), E2 on HCG-day, endometrial thickness, number of retrieved oocytes, metaphase II oocytes, embryos transferred and score of leading embryos transferred.
RESULTS: Patients in the DHEA group had a significantly higher live birth rate compared with controls (P<0.05). Miscarriage rate was higher in control group (P<0.05).
CONCLUSION: DHEA supplementation could have a beneficial effect on IVF outcome in infertile women with normal ovarian reserve.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24867068

Source DB:  PubMed          Journal:  Minerva Ginecol        ISSN: 0026-4784


  4 in total

Review 1.  Dehydroepiandrosterone treatment in women with poor ovarian response undergoing IVF or ICSI: a systematic review and meta-analysis.

Authors:  Meixiang Zhang; Wenbin Niu; Yu Wang; Jiawei Xu; Xiao Bao; Linlin Wang; Linqing Du; Yingpu Sun
Journal:  J Assist Reprod Genet       Date:  2016-04-19       Impact factor: 3.412

2.  Dehydroepiandrosterone decreases the age-related decline of the in vitro fertilization outcome in women younger than 40 years old.

Authors:  Massimo Tartagni; Maria V Cicinelli; Domenico Baldini; Mario V Tartagni; Hala Alrasheed; Maria A DeSalvia; Giuseppe Loverro; Monica Montagnani
Journal:  Reprod Biol Endocrinol       Date:  2015-03-09       Impact factor: 5.211

3.  Sex Hormone Metabolism and Threatened Abortion.

Authors:  Qianhua Xu; Juan Chen; Zhaolian Wei; Theodore R Brandon; David T Zava; Yuenian Eric Shi; Yunxia Cao
Journal:  Med Sci Monit       Date:  2017-10-23

Review 4.  Biological and Clinical Rationale for Androgen Priming in Ovarian Stimulation.

Authors:  Kristine Løssl; Nina la Cour Freiesleben; Marie Louise Wissing; Kathrine Birch Petersen; Marianne Dreyer Holt; Linn Salto Mamsen; Richard A Anderson; Claus Yding Andersen
Journal:  Front Endocrinol (Lausanne)       Date:  2020-09-04       Impact factor: 5.555

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.